Previous studies reported that CD68-positive TAMs are a potential prognostic marker in breast cancer.17,22,31,32 However, we found that CD68-positive macrophages in tumor stroma mildly correlated with tumor relapse and were not significantly associated with TNBC patients outcome. This evidence concerns the gene CD68 and breast carcinoma.